Search

Your search keyword '"Masoodi, Tariq"' showing total 164 results
Start Over Author "Masoodi, Tariq" Publication Year Range Last 3 years
164 results on '"Masoodi, Tariq"'

5. Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.

Author

Dagar, Gunjan, Gupta, Ashna, Masoodi, Tariq, Nisar, Sabah, Merhi, Maysolun, Hashem, Sheema, Chauhan, Ravi, Dagar, Manisha, Mirza, Sameer, Bagga, Puneet, Kumar, Rakesh, Akil, Ammira S Al-Shabeeb, Macha, Muzafar A, Haris, Mohammad, Uddin, Shahab, Singh, Mayank, and Bhat, Ajaz A

Subjects
Humans, Neoplasms, Multiple Myeloma, Hematologic Neoplasms, Antigens, Neoplasm, Immunotherapy, Adoptive, Artificial Intelligence, Tumor Microenvironment, Cell- and Tissue-Based Therapy, Receptors, Chimeric Antigen, Antigen escape, CAR-T cell therapy, Cytokine release syndrome, Hematological malignancy, Immunotherapy, Solid tumor, Tumor antigens, Lymphoma, Biotechnology, Immunization, Hematology, Vaccine Related, Cancer, Rare Diseases, Genetics, Development of treatments and therapeutic interventions, 5.2 Cellular and gene therapies, Medical and Health Sciences, Immunology
Abstract

Traditional cancer treatments use nonspecific drugs and monoclonal antibodies to target tumor cells. Chimeric antigen receptor (CAR)-T cell therapy, however, leverages the immune system's T-cells to recognize and attack tumor cells. T-cells are isolated from patients and modified to target tumor-associated antigens. CAR-T therapy has achieved FDA approval for treating blood cancers like B-cell acute lymphoblastic leukemia, large B-cell lymphoma, and multiple myeloma by targeting CD-19 and B-cell maturation antigens. Bi-specific chimeric antigen receptors may contribute to mitigating tumor antigen escape, but their efficacy could be limited in cases where certain tumor cells do not express the targeted antigens. Despite success in blood cancers, CAR-T technology faces challenges in solid tumors, including lack of reliable tumor-associated antigens, hypoxic cores, immunosuppressive tumor environments, enhanced reactive oxygen species, and decreased T-cell infiltration. To overcome these challenges, current research aims to identify reliable tumor-associated antigens and develop cost-effective, tumor microenvironment-specific CAR-T cells. This review covers the evolution of CAR-T therapy against various tumors, including hematological and solid tumors, highlights challenges faced by CAR-T cell therapy, and suggests strategies to overcome these obstacles, such as utilizing single-cell RNA sequencing and artificial intelligence to optimize clinical-grade CAR-T cells.

Published
2023

6. Alternative Splicing in Cancer Drug Resistance

Author

Gupta, Ashna, primary, Chauhan, Ravi, additional, Sharma, Tarang, additional, Macha, Muzafar A., additional, Masoodi, Tariq, additional, Al-Shabeeb Akil, Ammira S., additional, Bhat, Ajaz A., additional, and Singh, Mayank, additional

Published
2024
Full Text
View/download PDF

7. Unleashing the Potential of Deep Learning for Precise Nuclei Segmentation and Classification in H &E-Stained Whole Slide Images

Author

Majeed, Tabasum, Aalam, Syed Wajid, Ahanger, Abdul Basit, Dar, Rayees Ahmad, Masoodi, Tariq Ahmad, Macha, Muzafar Ahmad, Bhat, Ajaz A., Bhat, Muzafar Rasool, Assad, Assif, Kacprzyk, Janusz, Series Editor, Gomide, Fernando, Advisory Editor, Kaynak, Okyay, Advisory Editor, Liu, Derong, Advisory Editor, Pedrycz, Witold, Advisory Editor, Polycarpou, Marios M., Advisory Editor, Rudas, Imre J., Advisory Editor, Wang, Jun, Advisory Editor, Pant, Millie, editor, Deep, Kusum, editor, and Nagar, Atulya, editor

Published
2024
Full Text
View/download PDF

9. Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India

Author

Bhat, Gh. Rasool, Jamwal, Rajeshwer Singh, Sethi, Itty, Bhat, Amrita, Shah, Ruchi, Verma, Sonali, Sharma, Minerva, Sadida, Hana Q., Al-Marzooqi, Sara K., Masoodi, Tariq, Mirza, Sameer, Haris, Mohammad, Macha, Muzafar A., Akil, Ammira S. Alshabeeb, Bhat, Ajaz A., and Kumar, Rakesh

Published
2023
Full Text
View/download PDF

11. Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progression

Author

Chauhan, Ravi, Gupta, Ashna, Malhotra, Lakshay, Bhat, Ajaz A., Pandita, Raj K., Masoodi, Tariq, Dagar, Gunjan, Sadida, Hana Q., Al-Marzooqi, Sara K., Batra, Atul, Bakhshi, Sameer, Sharma, Mehar Chand, Tanwar, Pranay, Khan, Shah Alam, Samath, Ethayathulla Abdul, Uddin, Shahab, Akil, Ammira S. Al-Shabeeb, Haris, Mohammad, Macha, Muzafar A., Pandita, Tej K., and Singh, Mayank

Published
2023
Full Text
View/download PDF

12. An integrated tumor, immune and microbiome atlas of colon cancer

Author

Roelands, Jessica, Kuppen, Peter J. K., Ahmed, Eiman I., Mall, Raghvendra, Masoodi, Tariq, Singh, Parul, Monaco, Gianni, Raynaud, Christophe, de Miranda, Noel F.C.C., Ferraro, Luigi, Carneiro-Lobo, Tatiana C., Syed, Najeeb, Rawat, Arun, Awad, Amany, Decock, Julie, Mifsud, William, Miller, Lance D., Sherif, Shimaa, Mohamed, Mahmoud G., Rinchai, Darawan, Van den Eynde, Marc, Sayaman, Rosalyn W., Ziv, Elad, Bertucci, Francois, Petkar, Mahir Abdulla, Lorenz, Stephan, Mathew, Lisa Sara, Wang, Kun, Murugesan, Selvasankar, Chaussabel, Damien, Vahrmeijer, Alexander L., Wang, Ena, Ceccarelli, Anna, Fakhro, Khalid A., Zoppoli, Gabriele, Ballestrero, Alberto, Tollenaar, Rob A.E.M., Marincola, Francesco M., Galon, Jérôme, Khodor, Souhaila Al, Ceccarelli, Michele, Hendrickx, Wouter, and Bedognetti, Davide

Published
2023
Full Text
View/download PDF

13. Unraveling the Esophageal Cancer Tumor Microenvironment: Insights and Novel Immunotherapeutic Strategies

Author

Khan, Inamu Rashid, Ali, Faizyana, Hashem, Sheema, Abdulla, Alanoud, Nisar, Sabah, Masoodi, Tariq, Al-Shabeeb Akil, Ammira S., Bhat, Ajaz A., Macha, Muzafar A., Rezaei, Nima, Series Editor, Ahmed, Atif A., Editorial Board Member, Aguiar, Rodrigo, Editorial Board Member, Ambrosio, Maria R., Editorial Board Member, Artac, Mehmet, Editorial Board Member, Augustine, Tanya N., Editorial Board Member, Bambauer, Rolf, Editorial Board Member, Bhat, Ajaz Ahmad, Editorial Board Member, Bertolaccini, Luca, Editorial Board Member, Bianchini, Chiara, Editorial Board Member, Cavic, Milena, Editorial Board Member, Chakrabarti, Sakti, Editorial Board Member, Cho, William C. S., Editorial Board Member, Czarnecka, Anna M., Editorial Board Member, Domingues, Cátia, Editorial Board Member, Eşkazan, A. Emre, Editorial Board Member, Fares, Jawad, Editorial Board Member, Fonseca Alves, Carlos E., Editorial Board Member, Fru, Pascaline, Editorial Board Member, Da Gama Duarte, Jessica, Editorial Board Member, García, Mónica C., Editorial Board Member, Gener, Melissa A.H., Editorial Board Member, Estrada Guadarrama, José Antonio, Editorial Board Member, Hargadon, Kristian M., Editorial Board Member, Holvoet, Paul, Editorial Board Member, Jurisic, Vladimir, Editorial Board Member, Kabir, Yearul, Editorial Board Member, Katsila, Theodora, Editorial Board Member, Kleeff, Jorg, Editorial Board Member, Liang, Chao, Editorial Board Member, Tan, Mei Lan, Editorial Board Member, Li, Weijie, Editorial Board Member, Prado López, Sonia, Editorial Board Member, Macha, Muzafar A., Editorial Board Member, Malara, Natalia, Editorial Board Member, Orhan, Adile, Editorial Board Member, Prado-Garcia, Heriberto, Editorial Board Member, Pérez-Velázquez, Judith, Editorial Board Member, Rashed, Wafaa M., Editorial Board Member, Sanguedolce, Francesca, Editorial Board Member, Sorrentino, Rosalinda, Editorial Board Member, Shubina, Irina Zh., Editorial Board Member, de Araujo, Heloisa Sobreiro Selistre, Editorial Board Member, Torres-Suárez, Ana Isabel, Editorial Board Member, Włodarczyk, Jakub, Editorial Board Member, Yeong, Joe Poh Sheng, Editorial Board Member, Toscano, Marta A., Editorial Board Member, Wong, Tak-Wah, Editorial Board Member, Yin, Jun, Editorial Board Member, and Yu, Bin, Editorial Board Member

Published
2023
Full Text
View/download PDF

14. Tight Junctions and Signaling Pathways in Cancer

Author

Khurshid, Sana, UlHaq, Burhan, Khursheed, Sadaf, Sadida, Hana Q., Masoodi, Tariq, Singh, Mayank, Akil, Ammira S. Al-Shabeeb, Bhat, Ajaz A., Macha, Muzafar A., Bhat, Ajaz A., editor, Haris, Mohammad, editor, Macha, Muzafar A., editor, and Dhawan, Punita, editor

Published
2023
Full Text
View/download PDF

15. Molecular Architecture and Function of Tight Junctions

Author

Kumar, Mudasir A., Khan, Tulaib Azam, Al Marzooqi, Sara K., Abdulla, Alanoud, Masoodi, Tariq, Akil, Ammira S. Al-Shabeeb, Bhat, Ajaz A., Macha, Muzafar A., Bhat, Ajaz A., editor, Haris, Mohammad, editor, Macha, Muzafar A., editor, and Dhawan, Punita, editor

Published
2023
Full Text
View/download PDF

17. Imaging Techniques to Study Tight Junctions

Author

Ali, Tayyiba Akbar, Akhtar, Sabah, Nisar, Sabah, Masoodi, Tariq, Reddy, Ravinder, Bhat, Ajaz A., Haris, Mohammad, Bhat, Ajaz A., editor, Haris, Mohammad, editor, Macha, Muzafar A., editor, and Dhawan, Punita, editor

Published
2023
Full Text
View/download PDF

23. SORBS1 expression as a biomarker for obesity and breast cancer prognosis: Insights from genomic analysis and survival outcomes.

Author

Bhat, Ajaz Ahmad, primary, Ahmed, Ikhlak, additional, Usmani, Shahabuddin, additional, Sadida, Hana. Q., additional, Masoodi, Tariq, additional, Kumar, Rakesh, additional, Singh, Mayank, additional, Mir, Manzoor Ahmad, additional, Mirza, Sameer, additional, Uddin, Shahab, additional, Macha, Muzafar Ahmad, additional, and Al-Shabeeb Akil, Ammira S, additional

Published
2024
Full Text
View/download PDF

34. Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression.

Author

Chauhan, Ravi, Malhotra, Lakshay, Gupta, Ashna, Dagar, Gunjan, Mendiratta, Mohini, Masoodi, Tariq, Hashem, Sheema, Al Marzooqi, Sara, Das, Dayasagar, Uddin, Shahab, Ethayathulla, Abdul Samath, Macha, Muzafar A., Akil, Ammira Al-Shabeeb, Sahoo, Ranjit Kumar, Rai, Ekta, Bhat, Ajaz A., and Singh, Mayank

Subjects
TUMOR suppressor proteins, CERVICAL cancer, GALECTINS, MATRIX metalloproteinases, VASCULAR endothelial growth factors, TUMOR suppressor genes
Abstract

Cervical cancer is still the leading cause of cancer mortality worldwide even after introduction of vaccine against Human papillomavirus (HPV), due to low vaccine coverage, especially in the developing world. Cervical cancer is primarily treated by Chemo/Radiotherapy, depending on the disease stage, with Carboplatin/Cisplatin-based drug regime. These drugs being non-specific, target rapidly dividing cells, including normal cells, so safer options are needed for lower off-target toxicity. Natural products offer an attractive option compared to synthetic drugs due to their well-established safety profile and capacity to target multiple oncogenic hallmarks of cancer like inflammation, angiogenesis, etc. In the current study, we investigated the effect of Bergenin (C-glycoside of 4-O-methylgallic acid), a natural polyphenol compound that is isolated from medicinal plants such as Bergenia crassifolia, Caesalpinia digyna, and Flueggea leucopyrus. Bergenin has been shown to have anti-inflammatory, anti-ulcerogenic, and wound healing properties but its anticancer potential has been realized only recently. We performed a proteomic analysis of cervical carcinoma cells treated with bergenin and found it to influence multiple hallmarks of cancers, including apoptosis, angiogenesis, and tumor suppressor proteins. It was also involved in many different cellular processes unrelated to cancer, as shown by our proteomic analysis. Further analysis showed bergenin to be a potent-angiogenic agent by reducing key angiogenic proteins like Galectin 3 and MMP-9 (Matrix Metalloprotease 9) in cervical carcinoma cells. Further understanding of this interaction was carried out using molecular docking analysis, which indicated MMP-9 has more affinity for bergenin as compared to Galectin-3. Cumulatively, our data provide novel insight into the anti-angiogenic mechanism of bergenin in cervical carcinoma cells by modulation of multiple angiogenic proteins like Galectin-3 and MMP-9 which warrant its further development as an anticancer agent in cervical cancer. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

41. Abstract 335: Ubiquitin Specific Peptidase 37promotes Osteosarcoma oncogenesis by interacting with PCNA and impacting constitutive replication fork movement.

Author

Chauhan, Ravi, primary, Malhotra, Lakshay, additional, Gupta, Ashna, additional, Bhat, Ajaz, additional, Dagar, Gunjan, additional, Masoodi, Tariq, additional, Macha, Muzafar A., additional, Samath, Ethayathulla Abdul, additional, Batra, Atul, additional, Sharma, Mehar Chand, additional, Haris, Mohammad, additional, Akil, Ammira Al-Shabeeb, additional, Pandita, Tej K., additional, Uddin, Shahab, additional, and Singh, Mayank, additional

Published
2023
Full Text
View/download PDF

42. Supplementary Table S4 from TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC

Author

Siraj, Abdul K., primary, Pratheeshkumar, Poyil, primary, Divya, Sasidharan Padmaja, primary, Parvathareddy, Sandeep Kumar, primary, Bu, Rong, primary, Masoodi, Tariq, primary, Kong, Yan, primary, Thangavel, Saravanan, primary, Al-Sanea, Nasser, primary, Ashari, Luai H., primary, Abduljabbar, Alaa, primary, Al-Homoud, Samar, primary, Al-Dayel, Fouad, primary, and Al-Kuraya, Khawla S., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure S1 from TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC

Author

Siraj, Abdul K., primary, Pratheeshkumar, Poyil, primary, Divya, Sasidharan Padmaja, primary, Parvathareddy, Sandeep Kumar, primary, Bu, Rong, primary, Masoodi, Tariq, primary, Kong, Yan, primary, Thangavel, Saravanan, primary, Al-Sanea, Nasser, primary, Ashari, Luai H., primary, Abduljabbar, Alaa, primary, Al-Homoud, Samar, primary, Al-Dayel, Fouad, primary, and Al-Kuraya, Khawla S., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Materials and Methods from TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC

Author

Siraj, Abdul K., primary, Pratheeshkumar, Poyil, primary, Divya, Sasidharan Padmaja, primary, Parvathareddy, Sandeep Kumar, primary, Bu, Rong, primary, Masoodi, Tariq, primary, Kong, Yan, primary, Thangavel, Saravanan, primary, Al-Sanea, Nasser, primary, Ashari, Luai H., primary, Abduljabbar, Alaa, primary, Al-Homoud, Samar, primary, Al-Dayel, Fouad, primary, and Al-Kuraya, Khawla S., primary

Published
2023
Full Text
View/download PDF

45. An Updated Review of Contribution of Long Noncoding RNA-NEAT1 to the Progression of Human Cancers

Author

Farzaneh, Maryam, primary, Masoodi, Tariq, additional, Ghaedrahmati, Farhoodeh, additional, Radoszkiewicz, Klaudia, additional, Anbiyaiee, Amir, additional, Sheykhi-Sabzehpoush, Mohadeseh, additional, Rad, Niloofar Khoshdel, additional, Uddin, Shahab, additional, Jooybari, Seyedeh Pardis Motiee, additional, Khoshnam, Seyed Esmaeil, additional, and Azizidoost, Shirin, additional

Published
2023
Full Text
View/download PDF

46. Analysis of the Inhibitory Effect of Flavonoids on H-Ras Protein: An Anticancer Drug Target

Author

Alhamdan, Adel A. and Masoodi, Tariq Ahmad

Abstract

Background: GTP-bound mutant forms of H-Ras (Harvey-Ras) proteins are found in almost 30 of human tumors. In the present in silico study, the inhibitory effect of different flavonoid compounds on mutant H-Ras protein p21 has been assessed. The inhibitory effect of flavonoids is compared with three known clinical anticancer drugs. Besides, these have been interacted with normal H-Ras and tumor necrosis factor (TNF) proteins for toxicity check. Results: Upon docking, it was found that flavonoids such as naringenin, daidzein, and hesperetin showed highest affinity (most negative ΔG), while rutin showed no affinity towards mutant H-Ras. The three clinical anticancer agents (erlotinib, letrozole and exemestane) showed binding energies in the range of –1.11 to –5.51 kcal/mol which is comparatively lower than the flavonoids indicating efficacy of flavonoids to prevent complex formation with Raf and thereby prevent downstream effects. However, flavonoids showed no interaction with normal H-Ras and TNF indicating little or no cytotoxicity. Conclusion: Our study demonstrates that flavonoids (naringenin, daidzein, and hesperetin) are effective drugs to inhibit complex formation between mutant H-Ras P21 and RBD of Raf.

Published
2024
Full Text
View/download PDF

47. Identification of a novel candidate HSD3B2 gene variant for familial hypospadias by whole-exome sequencing.

Author

Almaramhy, Hamdi Hameed, Samad, Firoz Abdul, Al-Harbi, Ghadeer, Zaytuni, Dimah, Imam, Syed Nazar, Masoodi, Tariq, and Shamsi, Monis Bilal

Subjects
GENETIC variation, HYPOSPADIAS, FAMILIAL spastic paraplegia, MALE reproductive organs, RECESSIVE genes, MISSENSE mutation, HEREDITY, HUMAN abnormalities
Abstract

Introduction: Hypospadias [MIM: 300633] is one of the most frequent congenital malformations of male external genitalia. The spectrum of genetic variants causing hypospadias is varied, with studies commonly implicating genes critical in the fetal steroidogenic pathway. This is the first genetic study on hypospadias from the Yemen ethnicity and the second to report HSD3B2 mutations in more than one affected individual from the same family. Material and methods: Surgical hypospadias repair was performed on two hypospadias-affected siblings from a consanguineous family. Whole-exome sequencing (WES) was performed to identify the potential pathogenic variant for hypospadias, which was later confirmed by Sanger sequencing. The identified variant was further analyzed for its pathogenicity by using in silico tools such as SIFT, PolyPhen-2, MutationAssessor, MutationTaster, FATHMM, and ConSurf. Results: We identified a novel missense mutation (Chr1:119964631T>A, c.507T>A, p. N169K) in 3β-hydroxysteroid 2-dehydrogenase (HSD3B2) gene by WES. Sanger sequencing confirmed that the variant segregated the disease in the family between the affected and non-affected individuals. Both patients are homozygous, while parents and two unaffected siblings are heterozygous carriers, indicating an autosomal recessive pattern of inheritance. The in silico analysis by all six in silico tools (SIFT, PolyPhen-2, MutationAssessor, MutationTaster, FATHMM, and ConSurf) predicted the variant to be pathogenic/deleterious. Discussion: An abnormal fetal steroidogenic pathway due to genetic influences may affect the development of the male genital tract, including the urethral tract closure and morphogenesis of male genitalia. Furthermore, the pathogenicity of the observed variant in this study, confirmed by multiple in silico tools, characterizes the influence HSD3B2 gene variants may have in the etiology of hypospadias. Conclusion: Understanding of pathogenic manifestation and inheritance of confounding genetic variants in hypospadias is a matter of great concern, especially in familial cases. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

48. Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy

Author

Bhat, Ajaz A., primary, Nisar, Sabah, additional, Singh, Mayank, additional, Ashraf, Bazella, additional, Masoodi, Tariq, additional, Prasad, Chandra P., additional, Sharma, Atul, additional, Maacha, Selma, additional, Karedath, Thasni, additional, Hashem, Sheema, additional, Yasin, Syed Besina, additional, Bagga, Puneet, additional, Reddy, Ravinder, additional, Frennaux, Michael P., additional, Uddin, Shahab, additional, Dhawan, Punita, additional, Haris, Mohammad, additional, and Macha, Muzafar A., additional

Published
2022
Full Text
View/download PDF

49. Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis

Author

Kuttikrishnan, Shilpa, primary, Masoodi, Tariq, additional, Sher, Gulab, additional, Bhat, Ajaz A., additional, Patil, Kalyani, additional, El-Elimat, Tamam, additional, Oberlies, Nicholas H., additional, Pearce, Cedric J., additional, Haris, Mohmmad, additional, Ahmad, Aamir, additional, Alali, Feras Q., additional, and Uddin, Shahab, additional

Published
2022
Full Text
View/download PDF

50. Abstract 6221: Tandem use of multi-omics and artificial intelligence identified novel prognostic and therapeutic biomarkers for head and neck squamous cell carcinoma

Author

Bhat, Ajaz A., primary, Masoodi, Tariq, additional, Mishra, Deepika, additional, Singh, Mayank, additional, Nisar, Sabah, additional, Hashem, Sheema, additional, Baba, Sana K., additional, Bagga, Puneet, additional, Reddy, Ravinder, additional, Bedognetti, Davide, additional, Uddin, Shahab, additional, El-Rifai, Wael, additional, Macha, Muzafar A., additional, and Haris, Mohammad, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results